Harness Therapeutics Appoints New Chair and Secures Funding
Deal News | Jan 27, 2025 | SV Health Investors, LLC
Harness Therapeutics has announced the appointment of Dr. Heather Preston as the new Chair of its board. This strategic appointment comes alongside the company securing a new funding round from Ono Venture Investment. The funding is intended to expedite the advancement of Harness Therapeutics' neurodegeneration pipeline, which aims to deliver transformational therapies in the field. The infusion of funding and leadership by Dr. Preston, who will bring her extensive experience in the biosciences and venture capital sectors to the company, marks a significant step for Harness Therapeutics. SV Health Investors, a private equity firm, is prominently involved in supporting Harness Therapeutics as it embarks on this ambitious pursuit. Ono Venture Investment's participation as a new investor underscores the potential and promise of Harness Therapeutics' pipeline projects.
Sectors
- Biotechnology
- Healthcare Investment
Geography
- United States – Harness Therapeutics and SV Health Investors are based in the United States.
- Japan – Ono Venture Investment, which has provided funding, is based in Japan.
Industry
- Biotechnology – The article involves Harness Therapeutics, a company working in the development pipeline for neurodegeneration therapies, which falls under the biotechnology sector.
- Healthcare Investment – SV Health Investors and Ono Venture Investment are involved in funding and investment in healthcare and life sciences, specifically biotechnology.
Financials
- Not Specified – New funding secured from Ono Venture Investment but the amount has not been disclosed.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Harness Therapeutics | Target Company | Company | A biotech company focused on developing treatments for neurodegenerative diseases. |
| SV Health Investors | Investor | Company | A private equity and venture capital firm focusing on investments in healthcare and life sciences. |
| Ono Venture Investment | New Investor | Company | A venture capital firm based in Japan, engaged in investments in life sciences and healthcare innovations. |
| Dr. Heather Preston | Chair of the Board | Person | Recently appointed as Chair of Harness Therapeutics, bringing experience from biosciences and venture capital. |